Trial Profile
Enumeration and Functional Evaluation of Regulatory T-cells in Psoriasis Patients Before and After Treatment With: Calcipotriol/Betamethasone, Acitretin, Narrow-Band UVB and Anti-TNF Alpha Therapy (Etanercept, Adalimumab and Infliximab).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Acitretin (Primary) ; Adalimumab (Primary) ; Betamethasone-dipropionate/calcipotriol (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 16 Nov 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2010-019129-32).
- 15 Nov 2010 New trial record